6163澳门银河网站_娱乐官网-welcome

Responsive image

Responsive image

Responsive image

Responsive image

6163澳门银河网站_娱乐官网-welcome

Products

Company Profile

Responsive image

SHANGHAI YINGRUI BIOPHARMA CO.,LTD

SHANGHAI YINGRUI BIOPHARMA CO.,LTD

Shanghai Yingrui Biopharma Co., Ltd. is a high-tech pharmaceutical and chemical product enterprise which specializes in R & D, production and sales of API and intermediates. The company has always been dedicated to R & D and production of antiviral and anti-tumor drugs, etc. The company is equipped with advanced production equipment and detection equipment...

Enterprise Display

News

Company Newsmore +

Fight against the Epidemic Together with You

2020-04-15

Supply Large Quantities of Oseltamivir Phosphate (CAS:

2020-04-15

Large Supply of Bromoacetone

2020-04-13

2020 YingRui year's meeting

2020-01-14

Lunar New Year Holiday Arrangement

2020-01-13

2019 CPHI China is successfully ended!

2019-06-25

Congratulations on the success of the new website of Yin

2019-06-25

Fight against the Epidemic Together

2020-04-15

Supply Large Quantities of Oseltami

2020-04-15

Large Supply of Bromoacetone

2020-04-13

2020 YingRui year's meeting

2020-01-14

Lunar New Year Holiday Arrangement

2020-01-13

2019 CPHI China is successfully ende

2019-06-25

Congratulations on the success of th

2019-06-25

Industry Newsmore +

Biopharmaceutical industry enters "fast lane", pharmac

2020-07-07

In 2020, multinational pharmaceutical companies will be

2020-06-11

This drug may become the next 10 billion dollar "magic

2020-05-21

US FDA approved the use of vascepa (icosapent ethyl) as

2019-12-17

FDA approved contact lenses to slow down the development

2019-12-17

Sansheng pharmaceutical signed a cooperation agreement w

2019-11-26

The main end point of the edition junior experiment of t

2019-11-26

Sutro biopharma released data on the safety and potentia

2019-10-30

Biopharmaceutical industry enters "

2020-07-07

In 2020, multinational pharmaceutica

2020-06-11

This drug may become the next 10 bil

2020-05-21

US FDA approved the use of vascepa (

2019-12-17

FDA approved contact lenses to slow

2019-12-17

Sansheng pharmaceutical signed a coo

2019-11-26

The main end point of the edition ju

2019-11-26

Sutro biopharma released data on the

2019-10-30

Home | About Us | News | Products | Technology Transfer | Job | Inquiry | Contact Us

Home | About us | News | Products
Technology Transfer | Job | Inquiry | Contact Us

Copyright © 2017-2020 SHANGHAI YINGRUI BIOPHARMA CO.,LTD 沪ICP备11038445号-1
TEL：+86-21-33585366(DDT)、34666753 FAX：+86-21-34979012
E-mail：info@shyrchem.com ADD：1885 Metropolitan Road, Minhang District, Shanghai Code：201108